Parallax Volatility Advisers’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,000	Closed	-$3.76M	–	3018
2023 Q1	$3.76M	Sell	35,000 -39,800	-53%	-$4.58M	0.01%	982
2022 Q4	$8.23M	Buy	+74,800	New	+$4.85M	0.01%	846

Other funds holding RXDX